UNLABELLED: This study investigated osteoporosis management trends from 1998 to 2006 among 808 primary care physicians involved in the US-based NORA (National Osteoporosis Risk Assessment) study. These results suggest some significant improvements in osteoporosis management over the past eight years. INTRODUCTION: The purpose of this study was to investigate osteoporosis management trends among a large cohort of primary care physicians (PCPs) involved in the US-based NORA (National Osteoporosis Risk Assessment) study. METHODS: In 2006, we undertook a resurvey of the 2,836 NORA PCPs who completed a baseline survey in 1998. Of the 2,199 PCPs for whom we had current contact information and who were still practicing, we collected usable surveys from 808 (37% response rate). RESULTS: From 1998 to 2006, more than double the percentage of NORA PCPs reported using BMDs "often" (35% vs. 87%). There was a doubling of the percentage of NORA PCPs who reported that a T-score of < or = -2.5 was the threshold indicating the presence of osteoporosis (34% vs. 67%). The percentage of NORA PCPs who reported using bone turnover markers to screen, diagnosis, or monitor osteoporosis almost tripled (19% vs. 55%). The percentage of patients prescribed or recommended hormone therapy dropped sixfold (67% to 11%), and the percentage of patients prescribed bisphosphonates increased fourfold from 15% to 59%. CONCLUSION: These results suggest some significant improvements in osteoporosis management over the past eight years.
UNLABELLED: This study investigated osteoporosis management trends from 1998 to 2006 among 808 primary care physicians involved in the US-based NORA (National Osteoporosis Risk Assessment) study. These results suggest some significant improvements in osteoporosis management over the past eight years. INTRODUCTION: The purpose of this study was to investigate osteoporosis management trends among a large cohort of primary care physicians (PCPs) involved in the US-based NORA (National Osteoporosis Risk Assessment) study. METHODS: In 2006, we undertook a resurvey of the 2,836 NORA PCPs who completed a baseline survey in 1998. Of the 2,199 PCPs for whom we had current contact information and who were still practicing, we collected usable surveys from 808 (37% response rate). RESULTS: From 1998 to 2006, more than double the percentage of NORA PCPs reported using BMDs "often" (35% vs. 87%). There was a doubling of the percentage of NORA PCPs who reported that a T-score of < or = -2.5 was the threshold indicating the presence of osteoporosis (34% vs. 67%). The percentage of NORA PCPs who reported using bone turnover markers to screen, diagnosis, or monitor osteoporosis almost tripled (19% vs. 55%). The percentage of patients prescribed or recommended hormone therapy dropped sixfold (67% to 11%), and the percentage of patients prescribed bisphosphonates increased fourfold from 15% to 59%. CONCLUSION: These results suggest some significant improvements in osteoporosis management over the past eight years.
Authors: L Pérez-Edo; M Ciria Recasens; C Castelo-Branco; P Orozco López; A Gimeno Marqués; C Pérez; J Manasanch Dalmau Journal: Osteoporos Int Date: 2004-01-27 Impact factor: 4.507
Authors: Russel Burge; Bess Dawson-Hughes; Daniel H Solomon; John B Wong; Alison King; Anna Tosteson Journal: J Bone Miner Res Date: 2007-03 Impact factor: 6.741
Authors: Sylvie Perreault; Alice Dragomir; Alain Desgagné; Lucie Blais; Michel Rossignol; Julie Blouin; Yola Moride; Louis-Georges Ste-Marie; Julio Cesar Fernandès Journal: Pharmacoepidemiol Drug Saf Date: 2005-10 Impact factor: 2.890
Authors: L Joseph Melton; Cynthia S Crowson; W Michael O'Fallon; Heinz W Wahner; B Lawrence Riggs Journal: J Bone Miner Res Date: 2003-02 Impact factor: 6.741
Authors: E Barrett-Connor; S W Wade; R W Downs; T Ganiats; M Hochberg; R R Recker; B S Stolshek Journal: Osteoporos Int Date: 2015-04-16 Impact factor: 4.507
Authors: O Bruyère; D Nicolet; S Compère; V Rabenda; P Jeholet; B Zegels; P Maassen; G Pire; J Y Reginster Journal: Rheumatol Int Date: 2012-07-29 Impact factor: 2.631
Authors: E Barrett-Connor; K Ensrud; A N A Tosteson; S F Varon; M Anthony; N Daizadeh; S Wade Journal: Osteoporos Int Date: 2008-07-08 Impact factor: 4.507
Authors: Seong Hee Ahn; So Young Park; Jun-Il Yoo; Youn-Jee Chung; Yun Kyung Jeon; Byung-Ho Yoon; Ha Young Kim; Seung Hun Lee; Jehoon Lee; Seongbin Hong Journal: J Bone Metab Date: 2019-11-30